Mucolipidosis is a group of inherited metabolic disorders that affect the body's ability to carry out the normal turnover of various materials within cells. The name arose from a similarity in presentation to both the mucopolysaccharidoses and the sphingolipidoses. Four conditions, types I to IV, were historically labeled mucolipidoses, but type I, sialidosis, is now classed as a glycoproteinosis and type IV as a gangliosidosis. Types II and III result from a deficiency of the enzyme N-acetylglucosamine-1-phosphotransferase. The mucolipidoses are inherited in an autosomal recessive manner. Diagnosis is based on clinical symptoms, medical history and laboratory tests, with skeletal abnormalities, vision problems and developmental delays often present from birth or early childhood. No cure is known, and therapies address symptoms.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) Sources
1. Mucolipidosis (Wikipedia)
Genetics
The mucolipidoses are inherited in an autosomal recessive manner
lead sentence 1
Mucolipidosis is a group of inherited metabolic disorders that affect the body's ability to carry out the normal turnover of various materials within cells.
Lead: disease category
Mucolipidosis is a group of inherited metabolic disorders that affect the body's ability to carry out the normal turnover of various materials within cells.
View the SourceNational Library of Medicine: MeSH Descriptor Data: Mucolipidoses
National Library of MedicineMeSH tree number C10.228.140.163.100.435.590
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells.
MeSH tree number C05.116.198.371
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.